Back to EYPT

EyePoint Pharmaceuticals, Inc. 10-K

Accession 0001564590-21-012894

Filing information

CIK
0001314102
Report date
2020-12-31
Filing date
2021-03-12
Form
10-K
Primary document
eypt-10k_20201231.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.